About Gaussian
Gaussian is a company based in Wallingford (United States) founded in 1987. Gaussian has raised $3.54 million across 1 funding round from investors including UCL Technology Fund and BGF. Gaussian operates in a competitive market with competitors including PhaseCraft, HQS Quantum Simulations, HyperChem, Good Chemistry and Materials Nexus, among others.
- Headquarter Wallingford, United States
-
Sectors
Chemicals & Materials
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Gaussian, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$3.54 M (USD)
in 1 rounds
-
Latest Funding Round
$3.54 M (USD), Unspecified
Apr 20, 2023
-
Investors
UCL Technology Fund
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Gaussian
Unlock access to complete
Unlock access to complete
Funding Insights of Gaussian
Gaussian has successfully raised a total of $3.54M through 1 strategic funding round. The most recent funding activity was a Unspecified round of $3.54 million completed in April 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Gaussian
Gaussian has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include UCL Technology Fund and BGF.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on physical and life sciences companies
|
Locked | Locked | Locked | |
|
Early & Growth stage tech & offline focused VC firm funding companies in the UK & Ireland
|
Locked | Locked | Locked |
Investor details for Gaussian
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Gaussian
Investment portfolio details for Gaussian
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Gaussian
Detailed financials for Gaussian
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Gaussian Comparisons
Peer comparison for Gaussian
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Gaussian
Gaussian operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PhaseCraft, HQS Quantum Simulations, HyperChem, Good Chemistry and Materials Nexus, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Quantum simulation systems are provided for materials and chemical reactions.
|
|
| Locked | Locked | Locked |
Quantum simulation software for chemical and pharmaceutical sectors is provided.
|
|
| Locked | Locked | Locked |
Manufacturer of molecular modeling software
|
|
| Locked | Locked | Locked |
AI and cloud-powered quantum simulations for chemicals are provided.
|
|
| Locked | Locked | Locked |
AI-powered quantum simulation platform is developed for material discovery.
|
Detailed competitors of Gaussian
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Gaussian
Complete news archive for Gaussian
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Gaussian
Gaussian was founded in 1987 and raised its 1st funding round 36 years after it was founded.
Gaussian is headquartered in Wallingford, United States. It is registered at Wallingford, Connecticut, United States.
Gaussian is a funded company, having raised a total of $3.54M across 1 funding round to date.
Gaussian was founded in 1987 and is headquartered in Wallingford, United States. Computational chemistry software is developed and provided for modeling complex chemical reactions and substances. The product portfolio includes Gaussian, used for electronic structure modeling, and GaussView, which processes Gaussian input files through a graphical interface to perform calculations and interpret outputs like animated vibrations, property plots, and computed spectra. Operations focus on the scientific computing sector.
Gaussian's top competitors include HQS Quantum Simulations, PhaseCraft and Materials Nexus.
Gaussian has 2 investors. Key investors include UCL Technology Fund, and BGF.